A single vaccination with four-segmented rift valley fever virus prevents vertical transmission of the wild-type virus in pregnant ewes

Abstract Rift Valley fever virus (RVFV) is a mosquito-transmitted bunyavirus that causes severe outbreaks among wild and domesticated ruminants, of which sheep are the most susceptible. Outbreaks are characterised by high mortality rates among new-born lambs and abortion storms, in which all pregnan...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Paul J. Wichgers Schreur, Judith Oymans, Jet Kant, Sandra van de Water, Anna Kollár, Yves Dehon, Pál Soós, Zoltán Pénzes, Lucien van Keulen, Jeroen Kortekaas
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/1e9c8640ac5846d8ac722749844df6e3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:1e9c8640ac5846d8ac722749844df6e3
record_format dspace
spelling oai:doaj.org-article:1e9c8640ac5846d8ac722749844df6e32021-12-02T11:56:23ZA single vaccination with four-segmented rift valley fever virus prevents vertical transmission of the wild-type virus in pregnant ewes10.1038/s41541-020-00271-72059-0105https://doaj.org/article/1e9c8640ac5846d8ac722749844df6e32021-01-01T00:00:00Zhttps://doi.org/10.1038/s41541-020-00271-7https://doaj.org/toc/2059-0105Abstract Rift Valley fever virus (RVFV) is a mosquito-transmitted bunyavirus that causes severe outbreaks among wild and domesticated ruminants, of which sheep are the most susceptible. Outbreaks are characterised by high mortality rates among new-born lambs and abortion storms, in which all pregnant ewes in a flock may abort their foetuses. In endemic areas, Rift Valley fever (RVF) can be controlled by vaccination with either inactivated or live-attenuated vaccines. Inactivated vaccines are safe for animals during all physiological stages, including pregnancy. However, optimal efficacy of these vaccines depends on multiple vaccinations and yearly re-vaccination. Live-attenuated vaccines are generally highly efficacious after a single vaccination, but currently available live-attenuated vaccines may transmit to the ovine foetus, resulting in stillbirths, congenital malformations or abortion. We have previously reported the development of a novel live-attenuated RVFV vaccine, named RVFV-4s. This vaccine virus was created by splitting the M genome segment and deleting the major virulence determinant NSs, and was shown to be safe even for the most susceptible species, including pregnant ewes. The demonstrated efficacy and safety profile suggests that RVFV-4s holds promise for veterinary and human application. The RVFV-4s vaccine for veterinary application, here referred to as vRVFV-4s, was shown to provide complete protection after a single vaccination of lambs, goats and cattle. In this work, we evaluated the efficacy of the vRVFV-4s vaccine in pregnant ewes. Anticipating on the extremely high susceptibility of pregnant ewes for RVFV, both a single vaccination and double vaccination were evaluated in two independent experiments. The combined results suggest that a single vaccination with vRVFV-4s is sufficient to protect pregnant ewes and to prevent transmission to the ovine foetus.Paul J. Wichgers SchreurJudith OymansJet KantSandra van de WaterAnna KollárYves DehonPál SoósZoltán PénzesLucien van KeulenJeroen KortekaasNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 6, Iss 1, Pp 1-9 (2021)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Paul J. Wichgers Schreur
Judith Oymans
Jet Kant
Sandra van de Water
Anna Kollár
Yves Dehon
Pál Soós
Zoltán Pénzes
Lucien van Keulen
Jeroen Kortekaas
A single vaccination with four-segmented rift valley fever virus prevents vertical transmission of the wild-type virus in pregnant ewes
description Abstract Rift Valley fever virus (RVFV) is a mosquito-transmitted bunyavirus that causes severe outbreaks among wild and domesticated ruminants, of which sheep are the most susceptible. Outbreaks are characterised by high mortality rates among new-born lambs and abortion storms, in which all pregnant ewes in a flock may abort their foetuses. In endemic areas, Rift Valley fever (RVF) can be controlled by vaccination with either inactivated or live-attenuated vaccines. Inactivated vaccines are safe for animals during all physiological stages, including pregnancy. However, optimal efficacy of these vaccines depends on multiple vaccinations and yearly re-vaccination. Live-attenuated vaccines are generally highly efficacious after a single vaccination, but currently available live-attenuated vaccines may transmit to the ovine foetus, resulting in stillbirths, congenital malformations or abortion. We have previously reported the development of a novel live-attenuated RVFV vaccine, named RVFV-4s. This vaccine virus was created by splitting the M genome segment and deleting the major virulence determinant NSs, and was shown to be safe even for the most susceptible species, including pregnant ewes. The demonstrated efficacy and safety profile suggests that RVFV-4s holds promise for veterinary and human application. The RVFV-4s vaccine for veterinary application, here referred to as vRVFV-4s, was shown to provide complete protection after a single vaccination of lambs, goats and cattle. In this work, we evaluated the efficacy of the vRVFV-4s vaccine in pregnant ewes. Anticipating on the extremely high susceptibility of pregnant ewes for RVFV, both a single vaccination and double vaccination were evaluated in two independent experiments. The combined results suggest that a single vaccination with vRVFV-4s is sufficient to protect pregnant ewes and to prevent transmission to the ovine foetus.
format article
author Paul J. Wichgers Schreur
Judith Oymans
Jet Kant
Sandra van de Water
Anna Kollár
Yves Dehon
Pál Soós
Zoltán Pénzes
Lucien van Keulen
Jeroen Kortekaas
author_facet Paul J. Wichgers Schreur
Judith Oymans
Jet Kant
Sandra van de Water
Anna Kollár
Yves Dehon
Pál Soós
Zoltán Pénzes
Lucien van Keulen
Jeroen Kortekaas
author_sort Paul J. Wichgers Schreur
title A single vaccination with four-segmented rift valley fever virus prevents vertical transmission of the wild-type virus in pregnant ewes
title_short A single vaccination with four-segmented rift valley fever virus prevents vertical transmission of the wild-type virus in pregnant ewes
title_full A single vaccination with four-segmented rift valley fever virus prevents vertical transmission of the wild-type virus in pregnant ewes
title_fullStr A single vaccination with four-segmented rift valley fever virus prevents vertical transmission of the wild-type virus in pregnant ewes
title_full_unstemmed A single vaccination with four-segmented rift valley fever virus prevents vertical transmission of the wild-type virus in pregnant ewes
title_sort single vaccination with four-segmented rift valley fever virus prevents vertical transmission of the wild-type virus in pregnant ewes
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/1e9c8640ac5846d8ac722749844df6e3
work_keys_str_mv AT pauljwichgersschreur asinglevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT judithoymans asinglevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT jetkant asinglevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT sandravandewater asinglevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT annakollar asinglevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT yvesdehon asinglevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT palsoos asinglevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT zoltanpenzes asinglevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT lucienvankeulen asinglevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT jeroenkortekaas asinglevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT pauljwichgersschreur singlevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT judithoymans singlevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT jetkant singlevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT sandravandewater singlevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT annakollar singlevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT yvesdehon singlevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT palsoos singlevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT zoltanpenzes singlevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT lucienvankeulen singlevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
AT jeroenkortekaas singlevaccinationwithfoursegmentedriftvalleyfeverviruspreventsverticaltransmissionofthewildtypevirusinpregnantewes
_version_ 1718394793977970688